Levetiracetam-d 6

Overview

Levetiracetam-d 6 is the deuterium labeled Levetiracetam. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis . Levetiracetam modulates HDAC levels ultimately silencing MGMT , thus increasing Temozolomide effectiveness. A chemosensitizer agent.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > DNA Methyltransferase

Product Information

• Catalog No.: HY-B0106S
• CAS No.: 1133229-29-4
• Molecular Formula: C8H8D6N2O2
• Molecular Weight: 176.25
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source